Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00329407 · ClinicalTrials.gov registry record · Phase 4
The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects
A Phase 4 study, sponsored by Boston University.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT00329407: Completed Phase 4 study, sponsored by Boston University.
NCT00329407 is a Phase 4 study that has completed, run by Boston University. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00329407, a Phase 4 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
This investigation will assess the effectiveness of topiramate in reducing ethanol consumption by alcohol dependent subjects. It also will seek to establish whether topiramate can be safely used in this population including whether it might be subject to abuse by alcohol dependent individuals. A secondary goal of this study is to assess the effects of topiramate on verbal fluency during treatment for alcohol dependence.
Primary Outcome
The primary outcome was the mean daily consumption of standard alcoholic drinks (14 g per ethanol) during the baseline week compared to week 10, the final week subjects were one maintenance dose of topirmate.
Interventions
- DRUG Topiramate (Topamax)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2003-09 |
| Est. Completion | 2008-06 |
| Phase | Phase 4 |
What the finished NCT00329407 record still lists
NCT00329407 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Topiramate (Topamax) is the first listed.
NCT00329407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00329407 about?
NCT00329407 is a clinical study titled "The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects". This investigation will assess the effectiveness of topiramate in reducing ethanol consumption by alcohol dependent subjects. It also will seek to establish whether topiramate can be safely used in this population including whether it might be subject to abuse by alcohol dependent individuals. A se...
What is the current status of trial NCT00329407?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2003-09. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00329407?
The interventions under investigation include: Topiramate (Topamax) (DRUG).
Who is sponsoring clinical trial NCT00329407?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00329407's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia